Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > 57,000 views, THTX YouTube video link below

<< Previous

Bullboard Posts

Next >>

Comment by qwerty22on Sep 27, 2022 9:02am

99 Views

Post# 34988865

RE:RE:RE:57,000 views, THTX YouTube video link below

Either this character just randomly landed on THTX or THTX put themselves in front of him. Honestly the second option seems like the worst.

I don't see how this vid has anything to do with building their business

realitycheck4u wrote:

-- And what have we learned within this video?. We have learned that filtering out information to the retail channel helps build momentum.

SPCEO1 wrote: Just about everything this gentleman says about Trogarzo is embarrassingly wrong.

TH1902 wrote: Was curious so I found the video that referenced THTX, here it is, starts around 4:30 point, pitched as a trade on FDA response expected Oct. 3rd

https://www.youtube.com/watch?v=O6tkOY0GTVI